Printer Friendly

Articles from M2 Pharma (September 4, 2018)

1-24 out of 24 article(s)
Title Author Type Words
Ablynx receives European marketing authorization for Cablivi. 153
ADx Healthcare Launches New Alzheimer's Genetic Test in Partnership with Helix. 306
Aetna Coverage Decision Extends Abbott's Pain Therapy Option in US. 647
Animalcare sells wholesale division for GBP2.65m. 217
Arrowhead Completes Dosing in Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease. 282
AstraZeneca fails to meet primary endpoint in anifrolumab trial. 128
Azeria Therapeutics raises GBP4m in Series A fundraising. 189
Azeria Therapeutics Receives Series A Investment from Sixth Element Capital. 554
BioArctic announces expansion of research collaboration with Uppsala University. 205
BioArctic Expands the Research Collaboration with Uppsala University Concerning Antibody-based Diagnostic Imaging of the Brain in Alzheimer Patients. 510
Cablivi Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura. 312
Eiger Reports Positive Meeting with FDA on Progeria Program. 616
FDA Approves Merck's Delstrigo a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and Pifeltro, an NNRTI, Both for the Treatment of HIV-1 in Appropriate Patients. 401
Genoptix Launches FDA-Authorized BCR-ABL MRDx TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna. 319
NovellusDx Ltd signs exclusive dealer agreement with Primetech Co Ltd for Japan. 168
Olon acquires API manufacturing facility in Mahad, India. 181
Olon acquires API manufacturing facility in Mahad. 233
OptiBiotix Health signs US licensing agreement. 208
Probiodrug appoints Dr Michael Schaeffer as executive VP of business and strategy. 190
Quidel Receives FDA Clearance, CLIA Waiver for Its Point-of-Care Sofia 2 Lyme Fluorescent Immunoassay for Use with Sofia 2 Instrument from Finger-Stick Whole Blood Specimens. 896
Sanofi wins EC's marketing authorisation for Cablivi (caplacizumab) for the treatment of acquired thrombotic thrombocytopenic purpura. 314
Shire completes USD2.4bn sale of Oncology business to Servier. 139
USFDA approves Jivi for hemophilia A patients. 131
Vitalnext presents positive data from Vital01 study at the 40th Congress of 'the European Society for Clinical Nutrition and Metabolism' in Madrid. Clinical report 280

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters